Rezolute (RZLT) Cash from Operations (2010 - 2026)
Rezolute recorded quarterly Cash from Operations of 13689000.0 in Q1 2026, up 32.8% quarter-over-quarter from 20370000.0 in Q4 2025, and up 21.33% year-over-year from 11282677.28 in Q1 2025.
Rezolute's Cash from Operations history runs 17 years deep, the most recent figure standing at 13689000.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 21.33% year-over-year to 13689000.0; the TTM figure through Mar 2026 stood at 73509000.0 (down 12.05% YoY), while the FY2025 annual figure was 69100000.0, down 20.45% from the prior year.
- Cash from Operations came in at 13689000.0 for Q1 2026 at Rezolute, up from 20370000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 7493000.0 in Q4 2022 to a low of 22020000.0 in Q2 2025.
- A 5-year average of 14618588.24 and a median of 13968000.0 in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations slumped 158.81% in 2022 and increased 21.33% in 2026, its largest moves.
- Rezolute's Cash from Operations stood at 7493000.0 in 2022, then tumbled by 73.76% to 13020000.0 in 2023, then dropped by 4.96% to 13666000.0 in 2024, then plunged by 49.06% to 20370000.0 in 2025, then jumped by 32.8% to 13689000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 13689000.0, 20370000.0, and 17430000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | -13.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.69 Mn |
| Mar 31, 2026 | -13.69 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Sep 30, 2025 | -17.43 Mn |
| Sep 30, 2025 | -17.43 Mn |
| Jun 30, 2025 | -22.02 Mn |
| Jun 30, 2025 | -22.02 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Mar 31, 2025 | -17.40 Mn |
| Dec 31, 2024 | -13.67 Mn |
| Dec 31, 2024 | -13.67 Mn |
| Sep 30, 2024 | -16.01 Mn |
| Sep 30, 2024 | -16.01 Mn |
| Jun 30, 2024 | -18.52 Mn |
| Jun 30, 2024 | -18.52 Mn |
| Mar 31, 2024 | -15.24 Mn |
| Mar 31, 2024 | -15.24 Mn |
| Dec 31, 2023 | -13.02 Mn |
| Dec 31, 2023 | -13.02 Mn |
| Sep 30, 2023 | -10.59 Mn |
| Sep 30, 2023 | -10.59 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Jun 30, 2023 | -11.35 Mn |
| Mar 31, 2023 | -18.05 Mn |
| Mar 31, 2023 | -18.05 Mn |
| Dec 31, 2022 | -7.49 Mn |
| Dec 31, 2022 | -7.49 Mn |
| Sep 30, 2022 | -7.59 Mn |
| Sep 30, 2022 | -7.59 Mn |
| Jun 30, 2022 | -12.11 Mn |
| Jun 30, 2022 | -12.11 Mn |
| Mar 31, 2022 | -13.97 Mn |
| Mar 31, 2022 | -13.97 Mn |
| Dec 31, 2021 | -7.20 Mn |
| Dec 31, 2021 | -7.20 Mn |
| Sep 30, 2021 | -6.34 Mn |
| Sep 30, 2021 | -6.34 Mn |
| Jun 30, 2021 | -5.23 Mn |
| Jun 30, 2021 | -5.23 Mn |
| Mar 31, 2021 | -5.40 Mn |
| Mar 31, 2021 | -5.40 Mn |
| Dec 31, 2020 | -6.26 Mn |
| Dec 31, 2020 | -6.26 Mn |
| Sep 30, 2020 | -3.55 Mn |
| Sep 30, 2020 | -3.55 Mn |
| Jun 30, 2020 | -4.08 Mn |
| Jun 30, 2020 | -4.08 Mn |
| Mar 31, 2020 | -5.68 Mn |
| Mar 31, 2020 | -5.68 Mn |
| Dec 31, 2019 | -5.48 Mn |
| Dec 31, 2019 | -5.48 Mn |
| Sep 30, 2019 | -8.93 Mn |
| Sep 30, 2019 | -8.93 Mn |
| Jun 30, 2019 | -3.77 Mn |
| Jun 30, 2019 | -3.77 Mn |
| Mar 31, 2019 | -8.46 Mn |
| Mar 31, 2019 | -8.46 Mn |
| Dec 31, 2018 | -1.65 Mn |
| Dec 31, 2018 | -1.65 Mn |
| Sep 30, 2018 | -1.43 Mn |
| Sep 30, 2018 | -1.43 Mn |
| Jun 30, 2018 | -3.88 Mn |
| Jun 30, 2018 | -3.88 Mn |
| Mar 31, 2018 | -2.18 Mn |
| Mar 31, 2018 | -2.18 Mn |
| Dec 31, 2017 | -3.15 Mn |
| Dec 31, 2017 | -3.15 Mn |
| Sep 30, 2017 | -4.91 Mn |
| Sep 30, 2017 | -4.91 Mn |
| Jun 30, 2017 | -3.64 Mn |
| Jun 30, 2017 | -3.64 Mn |
| Mar 31, 2017 | -3.61 Mn |
| Mar 31, 2017 | -3.61 Mn |
| Dec 31, 2016 | -3.09 Mn |
| Dec 31, 2016 | -3.09 Mn |
| Sep 30, 2016 | -2.97 Mn |
| Sep 30, 2016 | -2.97 Mn |
| Jun 30, 2016 | -3.15 Mn |
| Jun 30, 2016 | -3.15 Mn |
| Mar 31, 2016 | -2.54 Mn |
| Mar 31, 2016 | -2.54 Mn |
| Dec 31, 2015 | -2.28 Mn |
| Dec 31, 2015 | -2.28 Mn |
| Sep 30, 2015 | -2.51 Mn |
| Sep 30, 2015 | -2.51 Mn |
| Jun 30, 2015 | -1.96 Mn |
| Jun 30, 2015 | -1.96 Mn |
| Mar 31, 2015 | -1.91 Mn |
| Mar 31, 2015 | -1.91 Mn |
| Dec 31, 2014 | -1.74 Mn |
| Dec 31, 2014 | -1.74 Mn |
| Sep 30, 2014 | -1.47 Mn |
| Sep 30, 2014 | -1.47 Mn |
| Jun 30, 2014 | -2.10 Mn |
| Jun 30, 2014 | -2.10 Mn |
| Mar 31, 2014 | -707,581.00 |
| Mar 31, 2014 | -707,581.00 |
| Dec 31, 2013 | -365,273.00 |
| Dec 31, 2013 | -365,273.00 |
| Sep 30, 2013 | 3,671.00 |
| Sep 30, 2013 | 3,671.00 |
| Jun 30, 2013 | -232,742.00 |
| Jun 30, 2013 | -232,742.00 |
| Mar 31, 2013 | -651,675.00 |
| Mar 31, 2013 | -651,675.00 |
| Dec 31, 2012 | -398,509.00 |
| Dec 31, 2012 | -398,509.00 |
| Sep 30, 2012 | -345,039.00 |
| Sep 30, 2012 | -345,039.00 |
| Jun 30, 2012 | -285,382.00 |
| Jun 30, 2012 | -285,382.00 |
| Mar 31, 2012 | -461,835.00 |
| Mar 31, 2012 | -461,835.00 |
| Dec 31, 2011 | -21,184.00 |
| Dec 31, 2011 | -21,184.00 |
| Sep 30, 2011 | -13,552.00 |
| Sep 30, 2011 | -13,552.00 |
| Mar 31, 2011 | 5.00 |
| Mar 31, 2011 | 5.00 |
| Dec 31, 2010 | 12,301.00 |
| Dec 31, 2010 | 12,301.00 |
| Sep 30, 2010 | -25,000.00 |
| Sep 30, 2010 | -25,000.00 |